HOME >> BIOLOGY >> NEWS
Pioneering research on ALS muscle disease rewarded

Leuven - Amyotrophic Lateral Sclerosis (ALS) is an incurable paralyzing neurodegenerative disorder that strikes five out of every 100,000 persons. The disease usually affects healthy people in the most active period of their lives - without warning or previous family history. Researchers from VIB (the Flanders Interuniversity Institute for Biotechnology), under the direction of Prof. Peter Carmeliet (K.U.Leuven), have been the first to demonstrate the importance of the VEGF protein in this disease. This research is opening prospects for treating ALS, and these promising results are highly appreciated by the persons concerned. The patient organization, ALS Association, has just presented 3000 of collected funds to Peter Carmeliet's team; and Diether Lambrechts and Erik Storkebaum, also members of Prof. Carmeliet's research team, have received the Galenus Prize to the value of 6200.

Incurable muscle disease

ALS can strike anyone. The Chinese leader Mao Tse Tung, the Russian composer Dimitri Sjostakowitz, the legendary New York Yankee baseball player Lou Gehrig, and astrophysicist Stephen Hawking have all been afflicted with ALS. In addition, an unusually large number of top Italian soccer players, airline pilots, and soldiers from the Golf war have been stricken by this fatal disease. About half of them die within three years - some even in the first year - usually as a consequence of asphyxiation, while still 'in full possession of their faculties'.

In a patient with ALS, the nerve bundles that run to the muscles deteriorate. The patient then loses control over his muscles, progressively becoming totally paralyzed, while remaining - disconcertingly - mentally sound. The causative mechanism of this grave, debilitating disease - which has an enormous medico-social impact - remains obscure. At present, the disease is totally untreatable. The consequence is that many ALS patients elect for euthanasia, a very controversial solution. Genetic r
'"/>

Contact: Sooike Stoops
sooike.stoops@vib.be
32-9-244-6611
VIB, Flanders Interuniversity Institute of Biotechnology
16-Jun-2005


Page: 1 2

Related biology news :

1. Pioneering research on sleeping sickness wins MERIAL Award for Parasitology
2. Pioneering approach to wastewater treatment earns Stanford engineer the 2007 Stockholm Water Prize
3. Pioneering researcher Dr. Kenneth Lyons Jones receives genetics award from March of Dimes
4. Pioneering research into health benefits of beauty treatment
5. Pioneering ecologist Ruth Patrick honored by Federal-State Commission
6. Pioneering PET/CT research widens applications of imaging for diabetic foot
7. NIH gives $8M to University of Pittsburgh School of Medicine for myositis research
8. Saudi Arabias KAUST names WHOI first research partner
9. Multinational research: protecting ecology means understanding people, too
10. Newly created cancer stem cells could aid breast cancer research
11. Carnegie Mellons Peter Adams receives EPA research grant

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/16/2016)... , June 16, 2016 ... is expected to reach USD 1.83 billion by ... View Research, Inc. Technological proliferation and increasing demand ... are expected to drive the market growth. ... The development of advanced multimodal techniques ...
(Date:6/9/2016)... 2016  Perkotek an innovation leader in attendance control systems is proud to announce ... for employers to make sure the right employees are actually signing in, and to ... ... ... ...
(Date:6/7/2016)... , June 7, 2016  Syngrafii Inc. ... a business relationship that includes integrating Syngrafii,s patented ... branch project. This collaboration will result in greater ... the credit union, while maintaining existing document workflow ... http://photos.prnewswire.com/prnh/20160606/375871LOGO ...
Breaking Biology News(10 mins):
(Date:6/23/2016)... 2016 Andrew D ... http://doi.org/10.17925/OHR.2016.12.01.22 Published recently in ... from touchONCOLOGY, Andrew D Zelenetz , discusses ... care is placing an increasing burden on healthcare ... therapies. With the patents on many biologics expiring, ...
(Date:6/23/2016)... 22, 2016  Amgen (NASDAQ: AMGN ) ... QB3@953 life sciences incubator to accelerate the development ... laboratory space at QB3@953 was created to help high-potential ... for many early stage organizations - access to laboratory ... Amgen launched two "Amgen Golden Ticket" awards, providing each ...
(Date:6/22/2016)... , June 22, 2016   StockNewsNow.com , ... Video Interview with Dr. Nader Pourhassan , President ... company focused on the clinical development and potential commercialization ... of HIV infection, according to the company,s website (see ... on Tuesday, June 7 th , 2016, at the ...
(Date:6/22/2016)... DIEGO , June 22, 2016  Mesa ... has developed a testing platform designed specifically for ... formation of their scientific advisory board (SAB). Approved ... directors, the SAB is chartered to advise on ... disease assay platform. Led by Dr. Steve ...
Breaking Biology Technology:
Cached News: